Table 5 The incremental predictive value of the TyG-BMI index for MACE.

	C-Statistic	p-value	NRI (95% CI)	p-value	IDI (95% CI)	p-value
6 Months MACE
Model 3 without TyG-BMI	0.791(0.718,0.864)	Reference	Reference	Reference	Reference	Reference
Model 3	0.797(0.724,0.870)	0.001	0.455(0.200,0.710)	< 0.001	0.038(0.013,0.063)	0.003
1 Year MACE
Model 3 without TyG-BMI	0.791(0.744,0.838)	Reference	Reference	Reference	Reference	Reference
Model 3	0.807(0.763,0.849)	0.006	0.333(0.134,0.532)	0.001	0.034(0.013,0.055)	0.002
3 Years MACE
Model 3 without TyG-BMI	0.648(0.605,0.691)	Reference	Reference	Reference	Reference	Reference
Model 3	0.681(0.634,0.728)	< 0.001	0.257(0.104,0.409)	0.001	0.040(0.022,0.058)	< 0.001

Model 3: adjusted for age, gender, smoker, drinker, Hypertension, Diabetes, Previous MI, Previous PCI, Previous stroke, Previous arrhythmia, FH-CAD, Thrombolysis, Multi-vessel disease, Stenting, Timely PCI, LVEF, LVEDD, Killip class ≥ 2, anterior MI on ECG , TIMI grade 0–1 fow before PCI , Time from symptom onset to hospital arrival, TC, LDL-C, HDL-C, CK, CKMB, TnT, D-dimer, BUN, Ccr, use of ACEI/ARB, Beta-blockers, and CCB drugs. MACE major adverse cardiovascular events, HR hazard ratio, CI confidence interval, PCI percutaneous coronary intervention, MI myocardial infarction, FH-CAD family history of coronary artery disease, HR heart rate, BUN Blood urea nitrogen, Ccr creatinine clearance rate, TG triglyceride, TC total cholesterol, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, TnT Troponin T, CK creatine kinase, CK-MB creatine kinase-MB, LVEF left ventricle ejection fraction, LVEDD left ventricular end-diastolic dimension, ACEI angiotensin II coenzyme inhibitor, ARB angiotensin II receptor blocker, CCB calcium channel blocker, TIMI Thrombolysis In Myocardial Infarction.

Quick links

Search